Skip to content

The Effect Of Oral Capsules Of Jujube Fruit Extract On The Prevention Of Postpartum Depression

The Effect Of Oral Capsules Of Jujube Fruit Extract On The Prevention Of Postpartum Depression

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220424054639N1
Enrollment
128
Registered
2022-06-13
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum depression. Puerperal psychosis

Interventions

Intervention 1: Intervention group: Includes An Intervention Group That In Addition To Receiving Routine Care Performed By Midwives Working In Comprehensive Health Service Centers On Days 1-3, 10-15,

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Conscious Consent Of The Mother Women 18-40 Years Old Recent Pregnancy Asked No History Of Recurrent Miscarriage Or Infertility Resident Of Torbate Jam Live With His Wife On The 10th Day After Normal Delivery Without Complications (Complication: Any Obstetric Complications Such As High Blood Pressure, Diabetes Or Hospitalization Of The Mother Due To Postpartum Complications) Having A Low-Risk Pregnancy (Low-Risk Pregnancy: A Pregnancy That Has No Potential Side Effects That Threaten The Health Of The Mother And Fetus) Having A Mobile Phone Number No Stress, Depression And Severe Anxiety (Depression And Severe Anxiety: Scores Of 24 And Above On The Stress Subscale And 15 And More On The Anxiety Subscale And 21 And More On The DASS-21 Questionnaire) Score Less Than 12 On The Edinburgh Depression Test Do Not Be Allergic To Jujube No Accidents (Accidents Such As The Death Or Hospitalization Of A Family Member During The Last Three Months) Do Not Currently Be Treated For Depression Have No Medical History (Medical Conditions: Hypertension, Hypothyroidism And Parathyroidism, Heart Disease, Kidney Disease, Hypertension Under Treatment, Migraine, Epilepsy, Respiratory Disease, Hyperlipidemia, Diabetes) Do Not Have Any Mental Illness (Mental Illness: A History Of Depression Or Neurological Disease Or Any Other Mental Disorder According To The Patient)

Exclusion criteria

Exclusion criteria: Reluctance To Continue Research Do Not Take The Drug For Two Consecutive Days Incidence Of Jujube Allergy Major Stress During Study(Major Stress: Serious Illness Of Yourself Or A Spouse, Death Of A Loved One, Unemployment, Accidents And Severe Family Disputes) Depression While Studying With A Psychiatrist Diagnosis The Baby Has An Abnormality Or The Baby Dies Change Of Residence During The Study Smoking, Drinking Alcohol Or Taking Any Drugs

Design outcomes

Primary

MeasureTime frame
Depression Score Before And After The Intervention. Timepoint: At The Beginning Of The Study And At The End Of The Second, Fourth And Sixth Weeks After Entering The Study, The Depression Score Will Be Measured. Method of measurement: Edinburgh Postpartum Depression Screening Questionnaire.

Secondary

MeasureTime frame
Satisfaction With The Sex Of The Baby. Timepoint: At The Beginning Of The Study. Method of measurement: Demographic And Midwifery Profile Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Jahani Shoorab

Mashhad University of Medical Sciences

JAHANISHN@MUMS.AC.IR+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026